International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

IATDMCT Elections 2019

Candidates for the 2019-2021 IATDMCT Council

IATDMCT members are invited to vote in the IATDMCT Council Elections. The term of office of the elected candidates will begin after the Annual General Meeting to be held at the 2019 IATDMCT Congress in Foz do Iguassu, Brazil, from September 22-26, 2019.

A password to access the election system has been sent to all active IATDMCT members by email.
If you did not receive your password, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. for assistance.

Click here to cast your ballot
Deadline for voting is August 31, 2019.

 


Yusuke Tanigawara

IATDMCT President
Not open for nomination: Current President-Elect will become the IATDMCT President

Yusuke Tanigawara
Japan

[+] View Bio

Employment

  • 1998-present, Professor, Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Japan
  • 1998-2007, Director of Hospital Pharmacy, Keio University Hospital, Japan
  • 1993-1998, Associate Professor and Vice Director, Department of Pharmacy, Kobe University Hospital, Japan
  • 1991-1992, Honorary Research Fellow, School of Pharmacy, University of Manchester, U.K.
  • 1990-1993, Lecturer, Department of Pharmacy, Kyoto University Hospital
  • 1985-1990, Instructor, Department of Pharmacy, Kyoto University Hospital

Education & Certification

  • JSPHCS-certified Senior Oncology Pharmacist (JSOP), Japanese Society of Pharmaceutical Health Care and Sciences
  • Board Certified Oncology Pharmacy Specialist (BCOPS), Japanese Society of Hospital Pharmacists
  • Board Certified Supervisor Pharmacist, Japanese Society of Clinical Pharmacology and Therapeutics
  • Board Certified Pharmacist, Japanese Society of Clinical Pharmacology and Therapeutics
  • Pharmacist License of Japan
  • 1983, Ph.D. from Graduate School of Pharmaceutical Sciences, Kyoto University, Japan
  • 1980, MSc from Graduate School of Pharmaceutical Sciences, Kyoto University, Japan
  • 1978,   BSc from Faculty of Pharmaceutical Sciences, Kyoto University, Japan

Professional Activities

  • 2013-2017, IATDMCT Secretary (2 terms)
  • 2017, Chairman, 15th IATDMCT Congress 2017 in Kyoto
  • 2015-2017, Chair of Scientific Committee “TDM in Oncology”
  • Editorial Board, Therapeutic Drug Monitoring
  • 2005-2011, President, Japanese Society of Therapeutic Drug Monitoring (JSTDM)
  • Plenary Lecturer at 14th Congress of IATDMCT 2015 in Rotterdam
  • Plenary Lecturer at 12th Congress of IATDMCT 2011 in Stuttgart
  • Invited speaker at IATDMCT Regional Meeting in Guangzhou, China, 2016
  • Invited speaker at IATDMCT Regional Meeting in Sibiu, Romania, 2014
  • Invited speaker at IATDMCT Regional Meeting in Beijing, China, 2010
  • Symposium speaker and organizer at the IATDMCT Congresses (Vienna in 1995, Cairns in 1999, Montreal in 2009)
  • Number of peer reviewed original articles: 183
  • Book chapters and Review articles: 250
  • Invited lectures at international conferences: 46
  • Invited lectures at Japanese national conferences: 117
  • Dr. Tanigawara was distinguished as “Highly Cited Researcher” by Thomson Reuters ISI database.  His research interests include clinical pharmacokinetics, pharmacodynamics and pharmacogenomics and their applications to TDM.  He also investigates multi-omics biomarkers by means of MS-based proteomics and metabolomics.

Other academic and professional appointments:

  • 2003-present, Executive Board member, Japanese Society of Therapeutic Drug Monitoring (JSTDM)
  • 2015-present, Executive Board member, Japanese Society of Clinical Oncology (JSCO)
  • 2006-present, President, Population Approach Group in Japan
  • 2016-present, Co-chair, Focus Group “Modeling and Simulation,” International Society for Study of Xenobiotics (ISSX)
  • 2011, Fellow of the Japanese Society for Study of Xenobiotics (JSSX)
  • 2007-2009, Delegate for the Board of Pharmaceutical Sciences, International Pharmaceutical Federation (FIP)
  • 2005-2008 and 2010-2014, Executive Board member, Japanese Society of Clinical Pharmacology and Therapeutics
  • 2008-2016, Executive Board member, Japanese Society of Pharmaceutical Health Care and Science
  • 2007-2009, Executive Board member, The Pharmaceutical Society of Japan
  • 2005-present, Council member, Japanese Society of Clinical Oncology
  • 2007-present, Council member, Japanese Society of Medical Oncology
  • 2009-present, Council member, Japanese Cancer Association
  • 2003-present, Council member, Japanese Society of Chemotherapy
  • 2003-present, Council member, Japanese Society for Pharmacoepidemiology
  • 2002-present, Associated Editor, Cancer Science
  • 2005-present, Editorial Board, Japanese Journal of Clinical Oncology
  • 2010-present, Editorial Board, The Japanese Journal of Antibiotics
  • 1999-2001, Editorial Board, European Journal of Pharmaceutical Sciences

Vision Statement
During last 4 years when I served as Secretary, the number of members remarkably increased from 400 to 600.  This was primarily due to expansion to new regions such as Asia.  I will continue to expand the network worldwide.  The key driver will be evolution of science and technology of TDM and CT.  Education is also important.  Young/Junior members account for 45% of total membership, and it is very important to continuously encourage their activity.


Teun van Gelder

IATDMCT Past President
Not open for nomination;Current President will become the Past President.

Teun van Gelder
Netherlands

[+] View Bio

Employment

  • 2010- Professor in Clinical Pharmacology
    Internist-clinical pharmacologist, Dept Hospital Pharmacy, Erasmus Medical Center - Rotterdam - NL
    Internist-nephrologist, Dept Internal Medicine, Erasmus Medical Center - Rotterdam - Netherlands
  • 2002-2010 Internist-clinical pharmacologist, Dept Hospital Pharmacy
    Internist-nephrologist, Dept Internal Medicine
    Both at Erasmus Medical Center - Rotterdam - The Netherlands
  • 2000-2002 Head of the Renal Transplantation Unit - Dept Internal Medicine - Erasmus Medical Center
  • 1998-1999 Post-doctoral fellow Dept Cardiothoracic Surgery -
    Laboratory for Transplantation Immunology, Stanford University - Palo Alto - USA
  • 1996-1998 Internist-nephrologist, Erasmus Medical Center - Rotterdam - The Netherlands
  • 1993-1996 Internist, Erasmus Medical Center - Rotterdam - The Netherlands
  • 1988-1993 Resident Internal Medicine, Erasmus Medical Center - Rotterdam - The Netherlands
  • 1987-1988 MD in (mandatory) Military Service

Education & Certification

  • Clinical Pharmacology (certification: December 1, 2003)
    Trained at University Medical Center Nijmegen – Netherlands in 2002-2003
  • Post-doctoral fellowship (Transplantation Immunology)
    Stanford University 1998-1999 (Professor Randall E Morris)
  • Thesis (Erasmus University Rotterdam) date : May 15, 1996 PhD. Title of thesis "The role of anti Interleukin-2 receptor monoclonal antibody (BT563) in the prevention of acute rejection after organ transplantation"
  • Nephrology (certification April 16, 1996)
    Trained at University Hospital Rotterdam 1995-1996
  • Internal Medicine (certification May 1, 1993)
    Trained at University Hospital Rotterdam 1988-1993
  • Medicine (certification as MD at Feb 20, 1987)
    Trained at Erasmus University Rotterdam 1980-1987 MD

Professional Activities

  • Since 2003 member of IATDMCT.
  • From 2005-2009 Councilor of IATDMCT
  • From 2009-2013 Director of Education within Council of IATDMCT
  • From 2009-2013 Chair of Immunosuppressive drugs committee of IATDMCT
  • From 2009 - 2015 Secretary of Dutch Transplantation Society
  • Since 2011 Chairman of Dutch Society for Clinical Pharmacology and Biopharmacy

Web-of-Science: 346 publications, H-index 39, with 6079 citations (as of March 2015)
Speaker at numerous conferences, both national and international.

Awards

  • 1994 Nephrology Award (Dutch Society for Nephrology)
  • 1996 Jon J. van Rood Award (Dutch Transplantation Society)
  • 1997 Young Investigator Award (European Society Heart Lung Transplantation)
  • 1998 International Young Investigator Award (American Society Transplant Physicians)
  • 2000 International Young Investigator Award (American Society of Transplantation)
  • 2005 Outstanding Speaker Award (American Association for Clinical Chemistry)
  • 2009 Visiting Professor Nephrology West China Medical School Chengdu (China)
  • 2010 Visiting Professor (Kathleen Valles Chair) St George’s Medical School London (UK)
  • 2011 Teacher of the year award (medical students – Erasmus University Rotterdam)

Vision Statement

Therapeutic drug monitoring and analysis+consulting for clinical toxicology are forms of personalized medicine “avant la lettre”. IATDMCT has promoted the individualization of treatment before the term personalized medicine had even been invented. Our strength is the analytical expertise and translation of laboratory results into practical treatment recommendations . My mission will be to promote the added value of our contribution, to increase the visibility of IATDMCT and to increase involvement of clinicians into our Association. 


Dario Cattaneo

IATDMCT President-Elect
Elected by acclamation

Dario Cattaneo
Italy

[+] View Bio

Employment

  • 2016-present, Coordinator of the outpatient clinics for the management of polytherapies in HIV-infected patients, L. Sacco University Hospital, Milano, Italy
  • 2004-2013, Component (Pharmacologist) of the Ethical Committee of the Scientific Institute E. Medea, Bosisio Parini, Lecco, Italy
  • 2003-2008, Component (Pharmacologist) of the Ethical Committee of the Bolognini Hospital of Seriate, Bergamo, Italy
  • 2004-2008, Head, Unit of Pharmacology and Pharmacogenetics, Mario Negri Institute for Pharmacological Research, Bergamo, Italy
  • 1997-2003, Research fellow, Mario Negri Institute for Pharmacological Research, Bergamo, Italy

Academic commitments

  • 2010-present, Assistant professor in Pharmacology, Faculty of Medicine, University of Milano, Italy
  • 2003-2011, Assistant Professor, Master in Transplant Medicine, University of Milano Bicocca, Italy
  • 2005-2008, Educational coordinator, Maastricht University (Belgium), within the Research Elective Agreement with the Mario Negri Institute for Pharmacological Research, Bergamo, Italy
  • 2004-2008, Assistant Professor, Master in Clinical Research, University of Milano, Italy
  • 2013-2017, Assistant Professor, Master in Pharmacovigilance and Pharmacoepidemiology, University of Naples, Italy

Education & Certification:

  • 1984-1989, High school diploma in Chemistry (Bergamo, Italy)
  • 1990-1995, Pharmacy Degree (University of Milano, Italy)
  • 1997-2000, Post-graduation specialization in Pharmacological Research (Mario Negri Institute for Pharmacological Research, Bergamo, Italy)
  • 1998-2001, Post-degree Specialization in Pharmacology (University of Milano, Italy)
  • 2001-2005, PhD in Biomedical Sciences (Open University, London, UK)

Professional Activities

  • 2005-present, International Association of Therapeutic Drug Monitoring and Clinical Toxicology
  • 2006-present, Italian Society of Pharmacology
  • 2016-present, Italian Society of Infectious Diseases and Tropical Medicine
  • 2019-present, European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
  • 2009-2016, American College of Clinical Pharmacology
  • 2018-present, Italian Federation of Human and Animal Mycology

Awards

  • 2001, Winner of the E. Cofferati award for the research activity in the field of immunosuppressant pharmacology
  • 2010, Winner of the D.E.I. Onlus Foundation award for the best emerging profiles in the field of clinical pharmacology

Publications / scientific activities

  • Author of nearly 200 publications on peer reviewed indexed international journals, cited more than 5000 times, H-index: 35
  • 7 book chapters
  • Invited speaker for nearly 50 international congresses
  • Invited speaker for nearly 200 national congresses
  • Referee activities for dozens of indexed international journals (> 500 manuscripts reviewed)
  • Member of the editorial board of European Journal of Drug Metabolism and Pharmacokinetics
  • Member of the editorial board of Therapeutic Drug Monitoring
  • Vice chair of the anti-infective committee within the IATDMCT society
  • Member of the ESCMID PK/PD of Anti-Infectives Study Group
  • Member of the board of directors of the Italian Federation of Human and Animal Mycology

Main clinical/research activities

  • Therapeutic drug monitoring (mainly anti-infective agents, immunosuppressants, and central nervous system drugs)
  • Pharmacokinetic studies both in healthy volunteers and in patients
  • Application of pharmacogenetics as diagnostic tool for the optimization of drug therapies
  • Antimicrobial stewardship
  • Study and assessment of potential drug-drug interactions in real life settings
  • Evaluation of potential inappropriate drug prescribing in fragile patients (deprescribing)
  • Development and validation of analytical methods for the quantification of drugs in different biological matrices

Vision Statement
I envisage the future of the IATDMCT society as the key player for the tailoring of drug therapy in increasingly complicated patients (elderly, with comorbidities and heavy polypharmacy) at the bedside, taking advantage from the presence of active members with excellences and expertise in several fields. The accomplishment of this task requires, however, a day-by-day, two-way strict collaboration with specialists from different medical disciplines. In other words, the labs need to meet/match the clinics!


Maria Shipkova

IATDMCT Secretary
Elected by acclamation

Maria Shipkova
Germany

[+] View Bio

Employment:

  • 2018, Medical Head Therapeutic Drug Monitoring, Synlab, Holding Germany GmbH, MVZ Leinfelden-Echterdingen
  • 2003-2018, Senior scientist and Head TDM/Tox Section, Institute of Clinical Chemistry and Laboratory, Medicine, Klinikum Stuttgart, Germany
  • 1999-2002, Resident Dept. of Clinical Chemistry, University Göttingen, Germany
  • 1995-1999, Postdoctoral fellow, Dept. of Clinical Chemistry, University Göttingen, Germany
  • 1992-1995, Resident Dept. of Clinical Chemistry, University Sofia, Bulgaria
  • 1991-1992, Resident Dept. Internal Medicine, University Sofia, Bulgaria

Education & Certification:

Academic Degrees:

  • Dr. med. University Göttingen, Germany, 2002
  • D-r (BG)., University Sofia, Bulgaria, 1990

Professional Registrations:

  • Fellow European Board of Laboratory Medicine/Medical Biopathology (F.E.B.L.M./M.B.), 2013
  • Clinical Pathology Consultant, 1996

Professional Activities

Professional Society Memberships:

  • Vereinte Deutsche Gesellschaft für Laboratoriumsmedizin und Klinische Chemie (DGKL)
  • International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
  • Transplantation Society
  • Bulgarian Academy of Sciences and Arts

Publications:

  • 115 articles contributed to scientific journals and book chapters on the following topics: therapeutic drug monitoring, drug metabolism, drug toxicity, development and evaluation of analytical methods, organ function tests, biomarkers of drug effects.

Stipends and Awards:

  • 2015, Grant from the Federal Ministry of Education and Research “Validation of GcfDNA based diagnostic test to detect organ damage after kidney transplantation”
  • 2011, Grant of the Pathobiochemistry and Molecular Diagnostics Foundation, DGKL, Analytical validation of biomarker assays in transplantation medicine
  • 2005, Young Investigator Award of the International Society for Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
  • 2004, Grant of the Pathobiochemistry and Molecular Diagnostics Foundation, DGKL, Acyl glucoronides of mycophenolic acid
  • 2002, Grant of the University Göttingen, Germany, Acyl glucuronide of mycophenolic acid
  • 1998, Stipend Volkswagen Foundation, Germany, Metabolism of immunosuppressants
  • 1996, Stipend Otvoreno Obschtestvo, Bulgaria, Pharmacokinetics of Taxol
  • 1995, Tempus Phare stipend of the EU, Therapeutic Drug Monitoring

Varia:

  • Secretary IATDMCT (2017 - )
  • Director of Education IATDMCT (2015 - 2017)
  • Vice-Chair IATDMCT Communication Committee (2011 - 2017)
  • Member of the IATDMCT Communication Committee (2011 -)
  • Member of the IATDMCT Biomarkers in transplantation Working Group (2009 - )
  • Coordinator “TDM of Everolimus” Consensus Project (2013-2016)
  • Past-Chair of the IATDMCT Immunosuppressive Drugs Scientific Committee (2013–2015)
  • Past Editor in Chief of the IATDMCT Newsletter “Compass” (2009 – 2015)
  • Member of the LOC of the 11th IATDMCT Congress, 2011, Stuttgart, Germany
  • Reviws Editor and Member the Editorial Board of Therapeutic Drug Monitoring (TDM)
  • Member of the Editorial Boards of Clinical Mass Spectrometry and Journal of Laboratory Medicine
  • Reviewer of publication for: Journal of Chromatography, Clinical Chemistry, Clinical Biochemistry, Clinica Chimica Acta, Transplant International, etc.

Vision Statement
As a longstanding member of IATDMCT for (>20 years) and somebody who had have the privilege to serve this Association at various positions over the past years I am glad to know many IATDMCT members and enjoy networking within IATDMCT. I hope that I have been able to convince with organizational-, communication-skills and persistence during my services and will be honored to continue my efforts for IATDMCT as a member of the Council.


Denise McKeown

IATDMCT Treasurer
Elected by acclamation

Denise McKeown
UK

[+] View Bio

Employment:

  • Sep 2012-Present: Forensic Medicine and Science (FMS), University of Glasgow, UK, Forensic Toxicologist
  • Dec 2002-Sep 2012: Analytical Services International (ASI), St George’s, University of London, UK, Senior Scientist in Clinical and Forensic Toxicology
  • Jul 2002-Nov 2002: Home Office Scientific Development Branch, Hertfordshire, UK, Scientific Contractor in Explosives and Drug Detection

Education & Certification:

  • Sep 1996-June 2002: University of Strathclyde, Glasgow, UK
  • MSci in Forensic and Analytical Chemistry

Professional Activities:

  • Member of International Association of TDM & Clinical Toxicology (IATDMCT)
    • Jan 2012-Dec 2017: Communications Committee (CC) Chair; (activities coordinated by CC: E-News, Social Media, Blog, Website / Resources Area, Compass etc)
    • Oct 2011-Oct 2015: Young Scientist Committee (YSC) Chair; (coordinated all YS activities: Congress YS workshops/symposia, social events and awards, and all non-Congress educational activities)
    • Sep 2007-Oct 2015: Compass Associate Editor
    • Apr 2005-Oct 2011: Young Scientist Committee (YSC) Vice-Chair
  • Member of The International Association of Forensic Toxicologists (TIAFT)
  • Member of UK and Ireland Association of Forensic Toxicologists (UKIAFT)
  • Member of London Toxicology Group (LTG)
  • Member of Royal Society of Chemistry (RSC)
  • Invited speaker and presented at national and international meetings
  • Contributed to several peer-reviewed publications and book chapters

Vision Statement
For 14 years I have been an active member with successful committee history. During decade as YSC Vice-Chair/Chair, YS membership increased from 8-296 members. Founding chair (past) of the very active CC, who are integral to association activities. Will continue devote same enthusiasm to role as Treasurer given the opportunity.


Director of Education
4 Candidates, 3 to be Elected


Jan Beumer

Jan Beumer
USA

[+] View Bio

Jan Hendrik Beumer is a Professor in the Department of Pharmaceutical Sciences at the University of Pittsburgh, School of Pharmacy.

Dr. Beumer received a Doctorate of Pharmacy in 2001 from the University of Utrecht, Faculty of Pharmaceutical Sciences, Utrecht, The Netherlands. Subsequently, he worked as a research pharmacist under the supervision of professor Jos H Beijnen, professor Jan HM Schellens and Dr. Olaf van Tellingen at the Department of Pharmacy and Pharmacology, Slotervaart Hospital / The Netherlands Cancer Institute, Amsterdam, The Netherlands, which, in 2004, resulted in a PhD from the University of Utrecht, Utrecht, The Netherlands. Subsequently, Dr. Beumer joined Professor Merrill Egorin's group at the University of Pittsburgh Cancer Institute through the School of Medicine, departmeant of heamatology/Oncology in 2005 as a post-doctoral associate.

Dr Beumer has established an active program of healthy volunteer drug-drug interaction studies, designed several phase I studies of novel combinations of anticancer agents, and has extensively researched pyrimidine anticancer drug pharmacology. He is an expert in preclinical and clinical metabolic studies, with a focus on mass balance studies. He also serves as Director of the University of Pittsburgh Cancer Institute Clinical Pharmacology Analytical Facility, which also functions as the core facility of the Gynecologic Oncology Group (GOG) and the Cancer and Leukemia Group B (CALGB). Through these roles, he is intimately involved in the design, execution, supervision and data analysis of numerous pharmacokinetic and metabolic studies of anti-cancer drugs covering the entire spectrum from preclinical to clinical phase II studies. For several years, he has been a co-investigator and is currently co-PI on an NCI N01 Animal Pharmacology Contract and I am co-PI of the UPCI NCI/CTEP U01 Phase I Grant.

Dr Beumer has published over 140 manuscripts in various peer-reviewed journals and has been been invited to present his work at national and international meetings including the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), PittCon, and the American Society for Clinical Pharmacology and Therapeutics (ASCPT).

Dr Beumer's goal is to study the translational pharmacology of anticancer drugs and to play a critical role in facilitating and mediating the preclinical and clinical drug development process. The translational science that is conducted in his laboratory provides significant contributions to the cancer research community at the University of Pittsburgh Cancer Institute, the Department of Pharmacutical Sciences, as well as at the NCI, various cooperative groups, other academic centers, and the pharmaceutical industry with the eventual goal of enhancing the quality of care of our cancer patients.


Debbie Marriott

Debbie Marriott
Australia

[+] View Bio

Employment:

  • Senior Specialist, Clinical Microbiology and Infectious Diseases, Clinical lead, anti-infectives therapeutic drug monitoring group, St. Vincent’s Hospital, Sydney, Australia
  • Visiting Medical Officer, St. Vincent's Private Hospital, Sydney
  • Visiting Medical Officer, Sacred Heart Hospice, Sydney
  • Conjoint Professor, School of Medicine, University of New South Wales
  • Adjunct Professor, Faculty of Science, University of Technology, Sydney

Education & Certification:

  • Fellow of the Royal College of Pathologists of Australasia (1986)
  • Fellow of the Royal Australasian College of Physicians (1985)
  • Bachelor of Medicine and Bachelor of Surgery, Honours Class I (1977)
  • Bachelor of Science (Medicine), Honours Class I (1974)

Professional Activities

  • Founding member and Past President of the Australasian Society for HIV Medicine
  • Past President, Transplant Infectious Diseases (a section of The Transplant Society)
  • International Councillor, International Association of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT)
  • Current chair of the Anti-Infectives group IATDMCT
  • Over 180 publications in refereed journals
  • Reviewer for over 10 journals
  • Associate editor, transplantation

Professional Societies

  • Royal Australasian College of Physicians
  • Royal College of Pathologists of Australasia
  • Australasian Society for Infectious Diseases
  • Australasian Society for HIV Medicine
  • Australasian Society for Antimicrobials
  • International Immuno-compromised Host Society
  • International Society for Heart and Lung transplantation
  • International Association for Therapeutic Drug Monitoring and Clinical Toxicology
  • Transplant Infectious Diseases
  • The Transplant Society
  • Animal Management in Remote and Indigenous Communities
  • 1986- Member, Drug and Therapeutics Committee, St. Vincent's Hospital
  • 1988- Accreditor, National Association of Testing Authorities
  • 1989-97 Member, N.S.W. State Committee, Royal Australasian College of Physicians
  • 1990- Examiner, Royal Australasian College of Pathologists
  • 1993–2014 Member, Tuberculosis Advisory Committee, N.S.W. Department of Health
  • 1995 Visiting lecturer, University Santo Tomas, Manila, Philippines
  • 1997-99 President, Australasian Society for HIV Medicine
  • 2000-10 Member, Pharmacology and Toxicology Working Group, National Centre in HIV Epidemiology and Clinical Research
  • 2009-13 Co-chair, Australian and New Zealand Mycoses Interest Group
  • 2010- Examiner, Royal Australasian College of Physicians
  • 2012- Scientific Committee member (HIV and Infectious Diseases), International Association for Therapeutic Drug Monitoring and Clinical Toxicology
  • 2012- Scientific Committee member, International Society for Heart and Lung Transplantation
  • 2012- Scientific Committee member, Transplant Infectious Diseases
  • 2013- President, Transplant Infectious Diseases
  • 2013-  Board Member, Medical Advances without Animals
  • 2014- Visiting Lecturer, The Academy of Medicine, Singapore
  • 2014- Visiting International Professor, Royal College of Pathologists of Australasia
  • 2014- Member, ESPAG group, ECCMID
  • Proposer and Co-Convener – joint IATDMCT/TID/The Transplant Society (TTS) Conference, Hong Kong, 2016 in conjunction with TTS Conference
  • Keynote and invited speaker at many national and international meetings including ICAAC (Denver 2012), IATDMCT (Salt Lake City 2012), ISHLT (Montreal, 2012; San Diego, 2013), The World Transplant Congress (San Francisco 2014), Transplant Infectious Diseases (Berlin, 2012; Vienna, 2013; Barcelona 2014), ISHAM (Melbourne 2015), Transplant Infectious Diseases (2014, 2015, 2016), IATDMCT (Rotterdam, 2016, Kyoto 2017, Brisbane 2018, Iguassu 2019)
  • Convener and speaker at a number of regional Mycology Master Classes run under the auspices of the International Society of Human and Animal Mycology (ISHAM) including Phuket (2011), Singapore (2012), Seoul (2013) and Penang (2014) and Bangkok (2016)
  • Coordinator of the Clinical Stream at the ISHAM conference in Melbourne (May 2015) and convener of the pre-congress workshop on Therapeutic Drug Monitoring in Fungal Infections
  • Invited speaker, 5th Annual National conference on Therapeutic Drug Monitoring and First Asia-Pacific Symposium on Therapeutic Drug Monitoring. Beijing, September 2015 and 6th Annual National Congress on Therapeutic Drug Monitoring. Nanjing, China. September 2016
  • Invited speaker and representative of IATDMCT with multiple presentations. The National Symposium on Therapeutic Drug Monitoring, Vellore, India, July 2017
  • Congress organizing committee, member of the scientific committee and invited speaker. 16th IATDMCT, Brisbane, Australia. September 2018
  • Extensive connections with the Asian region and an invited speaker at many conferences within Asia, including Malaysia, Hong Kong, Singapore, Indonesia, Japan and China
  • Reviewer of approximately 15 manuscripts per year for the past 5 years in local and international journals

Markus Meyer

Markus Meyer
Germany

[+] View Bio

Employment:

  • Chair of Experimental and Clinical Toxicology, Saarland University, Homburg, Germany
  • Clinical Pharmacology Heidelberg University Hospital, Heidelberg, Germany
  • Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden

Education & Certification:

  • Habilitation with Venia Legendi for Pharmacology & Toxicology
  • PhD
  • M.Sc., Pharmacist
  • Clinical toxicologist certified by GTFCh

Professional Activities:

  • Memberships in IADTMCT, TIAFT, GTFCh (German speaking society of forensic chemistry), DPhG (German society of pharmaceutical sciences), DGPT (German speaking society of pharmacology and toxicology), DGMS (German speaking society of mass spectrometry)
  • Activities in IATDMCT: Vice chair young scientist committee, Member of communication committee
  • Executive and committee positions held: TIAFT (Young scientist committee member), GTFCh (Chair of the continuous education program), IATDMCT (Councilor)
  • Number of publications: 150 PubMed-listed and peer-reviewed articles, numerous book chapters
  • Speaking engagements: Several invited talks at international conferences (USA, Europe, Asia)
  • Professional appointments: Clinical toxicologist GTFCh

Staffan Rosenborg

Staffan Rosenborg
Sweden

[+] View Bio

Employment:

  • Head of Clinical Trials, Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden (2017-present)
  • Head of the Clinical Pharmacology Trial unit, Karolinska University Hospital, Stockholm, Sweden (2013-2017)
  • Head of Residents in Clinical Pharmacology, Karolinska University Hospital, Stockholm Sweden, (2010-2013)
  • Director of Education (postgraduate training in Clinical Pharmacology at the Karolinska University Hospital (2010-2017)

Education & Certification:

  • Medical Doctor, Karolinska Institutet, Stockholm, Sweden (1996)
  • Specialist in Nephrology (2003)
  • Specialist in Clinical Pharmacology (2007)
  • PhD in Clinical Pharmacology, Karolinska Institutet (2010) Supervisor: Erik Eliasson and Leif Bertilsson, External examiner: Teun van Gelder
  • Swedish Diploma in Clinical Trials (2016)

Professional Activities:

  • Member of the IATDMCT since 2011
  • National representative in the UEMS (Union Européenne des Médecins Spécialistes) Section for Pharmacology since 2016
  • Director of Education of the IATDMCT since 2017
  • Initiated a symposium of Education in TDM and Clinical Toxicology at the IATDMCT conference in Brisbane in 2018
  • Member of the Editorial Board of the TDM journal (Ther Drug Monit) since 2019
  • 26 publications in Web of Science, h-index 10, 34 verified reviews on Publons
  • linkedin.com/in/staffan-rosenborg-50702a38

Councillors
4 Candidates, Elected by acclamation


Ryuji Kato

Ryuji Kato
Japan

[+] View Bio

Employment:

  • 2018-, Associate Professor, Osaka University of Pharmaceutical Sciences
  • 2016-2017, Visiting Professor, University of Toronto
  • 2012-2015, Lecturer, Osaka University of Pharmaceutical Sciences
  • 2005-2011, Assistant Professor, Osaka University of Pharmaceutical Sciences
  • 2002-2005, Hospital Pharmacist, Yokkaichi Social Insurance Hospital

Education & Certification:

  • 1996-2000, Faculty of Pharmacy, Kanazawa University (BS)
  • 2000-2002, Faculty of Pharmacy, Osaka University (MS)
  • 2008, Osaka University of Pharmaceutical Sciences (PhD)

Professional Activities:

  • 2000-, Member, Japanese Society of Pharmaceutical Health Care and Sciences
  • 2001-, Member, Japanese Society of Therapeutic Drug Monitoring (JSTDM)
  • 2001-, Member, Japanese Society for the Study of Xenobiotics
  • 2002-, Member, Japanese Society of Hospital Pharmacists
  • 2005-, Member, Pharmaceutical Society of Japan
  • 2005-, Member, Japan Society of Circulation Control in Medicine
  • 2009-, Member, International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
  • 2010-, Member, Japanese Society of Pharmaceutical Palliative Care and Sciences
  • 2011-, Member, Japanese Society of Clinical Pharmacology and Therapeutics
  • 2011-2015, Young Scientist Committee Member, IATDMCT
  • 2012-, Member, Japanese Society of Toxicology
  • 2012-, Member, Japanese Society of Nephrology and Pharmacotherapy (JSNP)
  • 2012-, Editorial Board Member, JSNP
  • 2014-2017, Chair of Young Scientist Committee, JSTDM
  • 2014-, Councilor, JSTDM
  • 2015-, Communication Committee Member, IATDMCT
  • 2015-, International Exchange Committee Member, JSTDM
  • 2015-, International Exchange Committee Member, JSNP
  • 2016-, Member, Society of Toxicology
  • 2017-, Inspector, JSTDM
  • I am author or co-author of more than 60 peer-reviewed manuscripts.

Christophe Stove

Christophe Stove
Belgium

[+] View Bio

Employment:

  • Feb 2018-now: Associate Professor (Lab of Toxicology, Ghent University)
  • Feb 2013-Jan 2018: Assistant-Professor (“tenure-track”) (Lab of Toxicology, Ghent University)
  • 2007-Jan 2013: Postdoc @ Faculty of Pharmaceutical Sciences (Lab of Toxicology, Ghent University)
  • 2004-2007: Postdoc @ Faculty of Sciences (VIB - Ghent University)
  • 2004: PhD in Medical Sciences (performed @ Faculty of Medical Sciences at Ghent University)

Education & Certification:

  • 1999: Pharmacist (Ghent University)
  • 2004: PhD in Medical Sciences (performed @ Faculty of Medical Sciences at Ghent University)
  • Official expert (toxicology), recognized by the Department of Justice, Belgium

Professional Activities:

  • Board / Council member of international and national scientific organisations (TIAFT, IATDMCT, BLT, BEMS); Former chair of the Alternative Sampling Strategies Committee of IATDMCT.
  • Member of scientific societies:
    • International Association for Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) (Council Member);
    • The International Association of Forensic Toxicologists (TIAFT) (Board Member);
    • Toxicological Society of Belgium and Luxemburg (BLT) (Board Member);
    • Belgian Environmental Mutagen Society (BEMS) (Board Member)
    • BelTox (Belgian Society of Toxicology and Ecotoxicology);
    • Belgian Society of Mass Spectrometry (BSMS);
    • American Chemical Society (ACS);
    • Belgisch Genootschap voor Farmaceutische Wetenschappen (BGFW);
    • Belgisch Genootschap voor Gerechtelijke Geneeskunde (BGGG).
  • Organizer of intra-faculty conferences, as well as an international conference on “Alternative Sampling Strategies in Toxicology and Therapeutic Drug Monitoring” (Sep 2015, ~180 attendants) and the 2018 congress of The International Association of Forensic Toxicology (TIAFT, Aug 2018, ~700 attendants); Organizing or Scientific Committee Member of numerous international conferences.
  • Editorial Board member of Therapeutic Drug Monitoring; Guest Editor of issues of Bioanalysis, Forensic Science International, Journal of Analytical Toxicology, Frontiers in Chemistry.
  • Referee for > 60 journals (>70 reviews/year; in 2018 most reviews for Anal Chem, J Chrom A, J Chrom B, TDM, Anal Bioanal Chem, Bioanalysis).
  • Member of the reading or examination committee of >50 PhD theses.
  • Acquisition of competitive research funding: ~1.75M€ projects + 31 person-years (PhD students & postdoc)
  • Promotor of 6 defended PhD’s and 10 ongoing PhD’s.
  • > 150 oral and poster presentations at national and international conferences (many on invitation).
  • 3 main research lines can be distinguished:
    • Alternative sampling strategies (e.g. dried blood microsampling, hair analysis)
    • Development of bio-assays for monitoring of activation of G-protein coupled receptors
    • Analysis of vitamers (amongst which folates and thiamins), their precursors and degradation products, in plant material and biological material (blood)
  • Publications (summary)
    • Total n° of A1 Publications: 115
    • Rankings: about 2/3 in Q1 & about 1/3 in Q2 journals; a substantial part in leading journals (Clin Chem, Anal Chem, …)
    • N° of publications since Jan 2014: 74
    • Total n° of Citations: 1962
    • H-index: 27
  • Responsible for the following courses:
    • General Toxicology (3rd Bachelor)
    • Bioanalysis (Master)
    • Chemical Criminalistics (Master)
    • Drug Toxicity (Master)
    • Supplements in Toxicology: advanced studies (MaNaMa Clinical Biology)
    • Co-responsible for Bioanalytical Practical Course
  • Head of the Laboratory of Forensic Toxicology, follow-up of routine casework in judicial cases since Jan 1st 2008; end responsible (lab director) since Sept 15, 2014. Provided many hundreds of reports to the Department of Justice since then.
  • Core member of the Forensic Institute of Ghent University (FI-UGent).
  • Toxicological consultancy; ad hoc toxicological expertise (e.g. Superior Health Council, Fonds Medische Ongevallen).
  • Involved in providing toxicological expertise in the train disaster at Wetteren (May 2013 - on-site expertise, scientific publications, part of the Superior Health Council, report to federal minister of public health, …).
  • Recognized by the Department of Justice as expert for determination of alcohol in cases of drunk driving (since Sept 4, 2014).
  • Director of the ISO 17025/1595 accredited Reference Laboratory Ref4U, implementing reference measurement procedures for e.g. thyroid hormones and vitamin D.

Nicolas Venisse

Nicolas Venisse
France

[+] View Bio

Employment:

  • Since 2013, Researcher, HEDEX research group (Health - Endocrine Disruptors – Exposome), Clinical Investigation Center (CIC 1402) INSERM (National Institute of Health and Medical Research), University hospital, Poitiers, France.
  • 2002 - 2009, Researcher, Pharmacology of antimicrobial agents, Inserm U1070, University of Poitiers, France.
  • 2003 - 2014, Head of Pharmacokinetics Unit, Toxicology and Pharmacokinetics department, University hospital, Poitiers, France.
  • Since 1999, Hospital Practitioner specialized in Therapeutic Drug Monitoring and Clinical Toxicology, Toxicology and Pharmacokinetics department, University hospital, Poitiers, France.

Education & Certification:

  • 2018, Accreditation to supervise research, Specialty Medicine (Habilitation à Diriger les Recherches, HDR), Faculty of Medicine and Pharmacy, University of Poitiers, France
  • Since 2017, Expert in Pharmacology and Toxicology at the Court of Appeal of Poitiers.
  • 2008, PhD in Pharmaceutical Sciences, Faculty of Medicine and Pharmacy, University of Poitiers, France
  • 2002, Master of Science, Faculty of Pharmacy, University of Tours and University of Paris, France
  • Since 1999, Registered to the French National Order of Pharmacists (Ordre National des Pharmaciens , Biologie Medicale)
  • 1999, Post-Graduate Specialist Diploma, Faculty of Pharmacy, University of Bordeaux 2, France
  • 1999, PharmD, Faculty of Pharmacy, University of Bordeaux 2, France

Professional Activities:

Activities in IATDMCT

    • Since 2017, Chair of the Toxicology and Environmental Health scientific committee at IATDMCT.
    • Since 2017, Organizer of symposiums at the Kyoto, Brisbane and Foz IATDMCT meetings
    • 2017, Launch of the new scientific committee dedicated to ToAcrxicology and Environmental Health at IATDMCT.
    • Since 2006, Member of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)

Other memberships

    • Since 2003, Member of the French Society of Pharmacology and Therapeutics (Societe Française de Pharmacologie et Therapeutique)
    • Since 2003, Member of Therapeutic Drug Monitoring subgroup from the French Society of Pharmacology and Therapeutics.

Professional appointments

  • Since 2019, Member of the French National Academy of Pharmacy
  • Since 2019, Member of the project selection committee, French National Research Program for Environmental and Occupation Health (PNREST), French Agency for Food, Environmental and Occupational Health & Safety (ANSES)
  • Since 2017, Member of the Regional Committee for Coordination against HIV/AIDS (COREVIH Nouvelle Aquitaine), Regional Health Agency (ARS Nouvelle Aquitaine)
  • Since 2017, Member of the Transplantation Committee, University Hospital of Poitiers
  • Since 2014, Member (elected) of the Hospital Medical Committee (Comission Medicale d’Etablissement), University Hospital of Poitiers
  • Author and co-author of more than 40 articles in peer-reviewed journals and 11 book chapters.
  • Recipient of research grants from French National Research Program for Environmental and Occupation Health (PNREST), French Agency for Food, Environmental and Occupational Health & Safety (ANSES) ; Fondation de France : Public Health and Environnement 2016 ; National Institute of Health and Medical Research (INSERM, ITMO Public Health)

Miao Yan

Miao Yan
China

[+] View Bio

Employment:

  • 01/2019 - present, Deputy Director of Scientific Research Department, the Second Xiangya Hospital of Central South University, China
  • 09/2017 - present, Associate Professor of Pharmacy, the Second Xiangya Hospital of Central South University, China
  • 05/2013 - 06/2014, Postdoctoral Research Fellow, University of Illinois at Chicago, USA
  • 09/2012 - 08/2017, Clinical Pharmacist, the Second Xiangya Hospital of Central South University, China

Education & Certification:

  • 09/2007 - 06/2010, Ph.D. in Pharmacology, Central South University, China
  • 09/2003 - 06/2006, M.S. in Natural Product Chemistry, Hunan University of Chinese Medicine, China
  • 09/1999 - 06/2003, B.S. in Pharmacy, Hunan University of Chinese Medicine, China

Professional Activities:

  • 10/2018 - present, Chair-Elect of Young Scientist Committee, Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society (CHINA-TDM)
  • 09/2018 - present, Member of TDM in Oncology Committee, IATDMCT
  • 09/2016 - present, Member of Young Scientist Committee, IATDMCT
  • 07/2015 - present, Member of Pharmacometrics Committee, Chinese Pharmacological Society
  • Published 48 research papers in Science Citation Index journals
  • [Oral presentation]. 2018 Congress of the International Association of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT); 2018 Sept 16-19, Brisbane, Australia
  • [Guest speaker]. The Third JSTDM-IATDMCT Young Scientist Joint Symposium at the 36th Annual Meeting of the Japanese Society of Therapeutic Drug Monitoring; 2019 May 25-26, Tokyo, Japan
  • [Invited speaker]. 2019 Congress of the International Association of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT); 2019 Sept 22-26, Foz do Iguassu, Brazil (Coming soon)
  • [Executive chair]. The First CHINATDM-IATDMCT Young Scientist Joint Symposium at the 9th International Xiangya Clinical Pharmacy Forum; 2019 Sept 5-7, Changsha, China (Coming soon)